Brandscouncil Ratings Survey 2024

Dr Nikunj Jain was honoured with the prestigious award of “Best Healthcare Founder” at Brandscouncil Ratings International Conclave & Awards 2024. It was given under the Brandscouncil Ratings Survey 2024 in its 3rd Phase on 12th December 2024 at the India International Centre (I.I.C.) in Lodhi Road, New Delhi.

Dr Nikunj Jain's visionary leadership, entrepreneurial prowess, and impact on the healthcare and diagnostics sector have been recognised and honoured with this award. His intelligence and vision have been essential to transforming Molecular Diagnostics and Therapy into a trusted provider of the industry's most innovative, high-quality, patient-focused healthcare solutions.

Throughout its history, the organisation has been at the forefront of innovation, bringing cutting-edge diagnostic technologies, improving standards of patient care and providing access to world-class healthcare services. 

His dedication to excellence has fostered a solid foundation for growth and ensured that patient care and wellbeing remain at the heart of all efforts. His professional accomplishments, along with his dedication to changing the healthcare industry through innovation and constant efforts toward improvement, are responsible for his recognition as Best Healthcare Founder.

It is a recognition of the vision, determination and commitment of the organisation over the years. It emphasises the role of good leadership in fostering positive change in the health services and health outcomes for communities. We are extremely proud of this milestone and view it as the culmination of the hard work of our great team, our health care partners and our stakeholders. They are always there to support and encourage us, which helps us to set our goals and sustain the highest level of service excellence.

We are dedicated to continuing to drive innovation in health services, excellence in practices and patient-centred care with the knowledge gained from this recognition. We are driven to seek out new frontiers and innovation, and aim to have a meaningful influence in the healthcare sector for years to come.